Warning letter

Long March Pharmaceuticals: warning letter of Sep 7, 1999

FDA warning letter UCM067648 · Center for Drug Evaluation and Research

Key facts

Reference number UCM067648
Company Long March Pharmaceuticals
Subject Pharmaceutical Manufacturing Facility/CGMP
Issue date Sep 7, 1999
Posted date Sep 7, 1999
Issuing office Center for Drug Evaluation and Research
Product type Drugs
Country 3
Letter on fda.gov web.archive.org

About FDA warning letters

FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.

Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date:

Browse all FDA warning letters